Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
US high school students reach lowest levels in math and reading in 20 years, raising concerns about their readiness for college and careers.
Oracle's stock surges on cloud growth outlook despite earnings miss, as its $455 billion backlog and ambitious AI-driven expansion plans captivate investors.
Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
US high school students reach lowest levels in math and reading in 20 years, raising concerns about their readiness for college and careers.
Oracle's stock surges on cloud growth outlook despite earnings miss, as its $455 billion backlog and ambitious AI-driven expansion plans captivate investors.